Words for describing activities that decrease and/or increase Subjective Well-Being. by August Håkan Nilsson (12937056)

Subjects:

Nasal microbiota features significantly associate with the presence of clinical signs. by Holly Kristin Arnold (14204655)

Gut microbiota features significantly associate with the presence of clinical signs. by Holly Kristin Arnold (14204655)

Gut and nasal microbiome features have significantly different pairwise distance distributions compared to null expectation. by Holly Kristin Arnold (14204655)

<i>SOX2</i> knockdown decreases OSCC cell migration and EMT. by Alessandro Sacco (8799386)

Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

Gut microbiome features significantly associated with clinical signs show evidence of phylogenetic clustering while nasal microbiome features show evidence of phylogenetic overdisp... by Holly Kristin Arnold (14204655)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

Subjects:

Parasite burden is significantly decreased in the small intestine of <i>taiep</i> infected rats. by Karen Elizabeth Nava-Castro (6940340)

Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe by Kaiyu Zhang (198799)

Subjects:

Discovery of Natural Products Alleviating Renal Fibrosis with a Viscosity-Responsive Molecular Probe by Kaiyu Zhang (198799)

Subjects:

H2: MP_t-2 x profit decreased. by Marie Finnegan (10036657)

CRISPRi knockdown of RgaR-dependent genes specifically and significantly decreases their transcript levels. by Adrianne N. Edwards (5646344)

Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

Subjects:

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects: